Understand how intelligent study design, focused data collection, and faster analytics can help clinical teams deliver meaningful results that sustain investor momentum.

Gain insight into why early toxicology readiness and strong scientific collaboration with CRO partners are critical to ...

Preserving trial integrity. Clinical trials are susceptible to timing. Delays in investigational product delivery can stall ...

Eli Lilly’s oral GLP-1 therapy, orforglipron, met all primary and key secondary endpoints in the Phase III ACHIEVE-2 and ACHIEVE-5 studies, showing significant A1C reduction, weight loss, and ...

Designing adhesion and durability for biopharmaceuticals in the most extreme cold chain environments.

Uncover how improving data accuracy and leveraging synthetic control arms can optimize trial efficiency, reduce costs, and ...

Examine strategies for validating, monitoring, and safely deploying configurable AI agents to ensure compliance and ...

This is the Applied Clinical Trials Brief —your fast track to the latest insights in clinical research operations. In under ...

Gain perspective on how agentic AI can bridge eCOA, EDC, IRT, and CTMS platforms to reduce manual effort and improve ...

While regulatory audits of IRT systems keep increasing, technical preparedness is the key to success in inspections. IRT systems are inherently high-risk due to their pivotal role in clinical trial ...

Take a closer look at how agentic AI can automate repetitive monitoring tasks while keeping human oversight central to critical decision-making in clinical research.